Zobrazeno 1 - 10
of 90
pro vyhledávání: '"T L, Krasnikova"'
Autor:
O I Afanasievа, E A Pylaeva, E A Klesareva, A V Potekhina, S I Provatorov, M I Afanasieva, T L Krasnikova, V P Masenko, T I Arefieva, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 88, Iss 9, Pp 31-38 (2016)
Aim. To study the role of lipoprotein(a) [Lp(a)] as a potential autoantigen causing the activation of immunocompetent cells in atherosclerosis. Subjects and methods. A total of 104 men with stable coronary artery (CA) disease and different degrees of
Externí odkaz:
https://doaj.org/article/c77ebc3f47e640ae93d6fe49b528ebe9
Autor:
E A Pylaeva, A V Potekhina, S I Provatorov, K V Raskina, N Iu RulEva, V P Masenko, E A Noeva, T L Krasnikova, T I Aref'eva
Publikováno v:
Терапевтический архив, Vol 86, Iss 9, Pp 24-30 (2014)
Pulmonary hypertension (PH) is a group of diseases characterized by progressive increases in pulmonary vascular resistance and pulmonary artery pressure, which results in right ventricular heart failure and sudden death. Based on the current version
Externí odkaz:
https://doaj.org/article/e43cc30e8bfd4708b4262b2825fd3e50
Autor:
Aleksandra Viktorovna Potekhina, Sergey Il'ich Provatorov, Tat'yana Igorevna Aref'eva, Nadezhda Borisovna Kukhtina, Valeriy Pavlovich Masenko, Elena Ivanovna Kaznacheeva, Natal'ya Yur'evna Ruleva, Elena Aleksandrovna Noeva, Mariya Konstantinovna Osyaeva, Mariya Vladimirovna Sidorova, Zhanna Dmitrievna Bespalova, Tat'yana Leonidovna Krasnikova, A V Potekhina, S I Provatorov, T I Arefyeva, N B Kukhtina, V P Masenko, E I Kaznacheyeva, N Yu Ruleva, E A Noyeva, M K Osyaeva, M V Sidorova, Zh D Bestalova, T L Krasnikova
Publikováno v:
Терапевтический архив, Vol 82, Iss 11, Pp 58-63 (2010)
Aim. To study the effect of the anti-inflammatory peptide preparation ingramon on the peripheral blood levels of inflammatory markers in patients with exercise-induced stable angina after coronary stenting (CS). Subjects and methods. The investigatio
Externí odkaz:
https://doaj.org/article/e9b1e3a87aae4e66a88929b0799e3b94
Autor:
Tat'yana Igorevna Aref'eva, Sergey Il'ich Provatorov, Aleksandra Viktorovna Potekhina, Vladimir Olegovich Sokolov, Nadezhda Borisovna Kukhtina, Anatoliy Nikolaevich Samko, Tat'yana Leonidovna Krasnikova, T I Arefieva, S I Provatorov, A V Potekhina, V O Sokolov, N B Kukhtina, A N Samko, T L Krasnikova
Publikováno v:
Терапевтический архив, Vol 81, Iss 9, Pp 33-37 (2009)
Aim. To investigate the effects of coronary stenting with rapamycin-eluting stents on parameters of cell immunity. Methods. 26 patients (group 1) with stable coronary heart disease and angiographically proved coronary stenosis underwent stenting with
Externí odkaz:
https://doaj.org/article/11846110bb8542fe8391fa6727585e23
Autor:
Pal'keeva Me, N. Yu. Ruleva, E A Pylaeva, A. S. Molokoedov, Maria Sidorova, Zh. D. Bespalova, A. A. Az’muko, T. L. Krasnikova, Tatiana I. Arefieva
Publikováno v:
Russian Journal of Bioorganic Chemistry. 41:10-18
The automated Fmoc solid-phase technique was used to synthesize Cys-containing linear peptide fragments of monocyte chemoattractant protein-1, chemokine domain of fractalkine, and their analogues, with the Cys residue being either modified or replace
Autor:
Zh. D. Bespalova, N. B. Kukhtina, A. A. Az’muko, T. L. Krasnikova, Maria Sidorova, N. Yu. Ruleva, Tatiana I. Arefieva
Publikováno v:
Russian Journal of Bioorganic Chemistry. 38:584-589
The CX3CL1 Fractalkine is the sole cytokine of the CX3C family. Its molecule consists of an extracellular N-terminal chemokine domain, a mucin-like rod, a transmembrane domain, and an intracellular domain. Fractalkine exhibits the properties of an ad
Autor:
M R, Akhmetshina, A B, Berdalin, M P, Morozova, S V, Buravkov, Zh D, Bespalova, M V, Sidorova, T I, Aref'eva, T L, Krasnikova, S A, Gavrilova
Publikováno v:
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. 101(7)
Monocyte chemotactic protein-1 (MCP-1) is a chemokine that stimulates monocytes and macrophage migration into the sites of acute of chronic inflammation. Our study shows morphological changes in ischemic myocardium followed by the administration of t
Autor:
Maria Sidorova, T. L. Bushueva, Petr I. Nikitin, Tatiana I. Arefieva, A. A. Az’muko, Zh. D. Bespalova, T. L. Krasnikova, S. G. Gorshkov, N. Yu. Ruleva, T. I. Ksenevich
Publikováno v:
Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 5:29-36
Monocyte chemotactic protein-1 (MCP-1, CCL2) is one of the most important chemokines involved in inflammation. MCP-1 stimulates migration of monocytes and certain lymphocyte populations to the affected area, in particular to the sites of atherosclero
Autor:
B. G. Gorshkov, T. L. Krasnikova, Maria Sidorova, E. N. Mamochkina, T. I. Ksenevich, A. V. Orlov, Zh. D. Bespalova, A. A. Az’muko, E E Efremov, Tatiana I. Arefieva, Petr I. Nikitin
Publikováno v:
Doklady Biological Sciences. 433:289-292
Autor:
T. L. Krasnikova, N. B. Kukhtina, Evgeny I. ChazovE.I. Chazov, Tatiana I. Arefieva, Maria Sidorova, Janna D. BespalovaJ.D. Bespalova, S I Provatorov
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 85:332-340
Inflammation plays an important role in vessel wall remodeling that occurs in atherosclerosis and postangioplasty restenosis. Monocytic chemoattractant protein-1 (MCP-1) is one of the main attractors of monocytes and some lymphocyte subsets to the da